ALFA Finder| Revenue growth | FY26 31.5% LFL; FY27 guided at 23% excluding new M&A. |
|---|---|
| Margins | Gross margin expanded 78bps to 10.3%; FY27 EBITDA target 5%. |
| Demand visibility | Strong organic momentum (15.6% vs IPM 1.6x). |
| Management confidence | High; delivered on all FY26 guidance parameters. |
Growth
FY26 revenue grew 31.5% LFL to ₹6,591cr; EBITDA margin reached 4% (+67bps YoY); PAT grew 36% YoY.
Outlook
FY27 guidance: 23% revenue growth (organic/calendarization) with 5% EBITDA margins; OCF conversion target of 50%.
Risks
Higher finance costs from debt-funded acquisitions; elevated depreciation from MedTech equipment rental models.
Earnings Call filed with BSE, BSE: 544122. Summary written with AI assistance from the document.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹2,019.10
- Market cap
- ₹8,796 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 63.1×Sector 54.5×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Legal & Regulatory
Entero's subsidiary Vasavi Medicare faces an INR 11.87 crore customer default. Vasavi has fully provided for the dues and plans legal recovery action.
- Value
- ₹11.87 Cr
Entero Healthcare Solutions Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 2,087 Cr (+32.9% reported, +34.7% LFL), EBITDA Rs 111 Cr at 5.3% margin, PAT Rs 61 Cr (+66%). Strategy: consolidate fragmented distribution and scale MedTech (IVD, cardio-ortho).
Entero Healthcare Solutions Q2 FY27 Results: Net Profit ₹60.7 Cr, Up 65.8% YoY
Entero Healthcare Solutions Ltd reported revenue from operations of ₹2,087 Cr (+32.9% YoY) and net profit of ₹60.7 Cr (+65.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹60.7 Cr · +65.8% YoY
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reports promoter and public holdings, with no transaction or corporate event.
Entero Healthcare Solutions Board Meeting Date
Entero Healthcare Solutions scheduled a board meeting for November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 2026.